Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in generalized anxiety disorder.

Lohoff FW, Narasimhan S, Rickels K.

Pharmacogenomics J. 2013 Oct;13(5):464-9. doi: 10.1038/tpj.2012.33. Epub 2012 Aug 21.

PMID:
22907732
2.

Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder.

Lohoff FW, Aquino TD, Narasimhan S, Multani PK, Etemad B, Rickels K.

Pharmacogenomics J. 2013 Feb;13(1):21-6. doi: 10.1038/tpj.2011.47. Epub 2011 Oct 18.

PMID:
22006095
3.

Association analysis between the A118G polymorphism in the OPRM1 gene and treatment response to venlafaxine XR in generalized anxiety disorder.

Cooper AJ, Rickels K, Lohoff FW.

Hum Psychopharmacol. 2013 May;28(3):258-62. doi: 10.1002/hup.2317. Epub 2013 May 8.

PMID:
23658070
4.

Association analysis between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and treatment response to venlafaxine XR in generalized anxiety disorder.

Narasimhan S, Aquino TD, Hodge R, Rickels K, Lohoff FW.

Neurosci Lett. 2011 Oct 10;503(3):200-2. doi: 10.1016/j.neulet.2011.08.035. Epub 2011 Aug 26.

PMID:
21889574
5.

Relation of serotonin transporter genetic variation to efficacy of escitalopram for generalized anxiety disorder in older adults.

Lenze EJ, Goate AM, Nowotny P, Dixon D, Shi P, Bies RR, Lotrich FK, Rollman BL, Shear MK, Thompson PA, Andreescu C, Pollock BG.

J Clin Psychopharmacol. 2010 Dec;30(6):672-7.

6.

Common selective serotonin reuptake inhibitor side effects in older adults associated with genetic polymorphisms in the serotonin transporter and receptors: data from a randomized controlled trial.

Garfield LD, Dixon D, Nowotny P, Lotrich FE, Pollock BG, Kristjansson SD, Doré PM, Lenze EJ.

Am J Geriatr Psychiatry. 2014 Oct;22(10):971-9. doi: 10.1016/j.jagp.2013.07.003. Epub 2013 Sep 8.

7.

Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.

Lin E, Chen PS, Chang HH, Gean PW, Tsai HC, Yang YK, Lu RB.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Oct 1;33(7):1167-72. doi: 10.1016/j.pnpbp.2009.06.015. Epub 2009 Jun 26.

PMID:
19560507
8.
9.

Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder.

Meoni P, Salinas E, Brault Y, Hackett D.

J Clin Psychiatry. 2001 Nov;62(11):888-93.

PMID:
11775049
10.
11.

Family-based association study of 5-HTTLPR and the 5-HT2A receptor gene polymorphisms with autism spectrum disorder in Korean trios.

Cho IH, Yoo HJ, Park M, Lee YS, Kim SA.

Brain Res. 2007 Mar 30;1139:34-41. Epub 2007 Jan 8.

PMID:
17280648
12.

Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.

Davidson JR, DuPont RL, Hedges D, Haskins JT.

J Clin Psychiatry. 1999 Aug;60(8):528-35.

PMID:
10485635
13.

Norepinephrine and serotonin transporter genes: impact on treatment response in depression.

Baffa A, Hohoff C, Baune BT, Müller-Tidow C, Tidow N, Freitag C, Zwanzger P, Deckert J, Arolt V, Domschke K.

Neuropsychobiology. 2010;62(2):121-31. doi: 10.1159/000317285. Epub 2010 Jun 30.

14.

Prediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trial.

Denys D, Van Nieuwerburgh F, Deforce D, Westenberg HG.

J Clin Psychiatry. 2007 May;68(5):747-53.

PMID:
17503984
15.

Serotonin transporter and serotonin receptor 2A gene polymorphisms in Alzheimer's disease.

Fehér A, Juhász A, László A, Pákáski M, Kálmán J, Janka Z.

Neurosci Lett. 2013 Feb 8;534:233-6. doi: 10.1016/j.neulet.2012.12.020. Epub 2012 Dec 27.

PMID:
23274704
16.

Pharmacogenetic Study of Serotonin Transporter and 5HT2A Genotypes in Autism.

Najjar F, Owley T, Mosconi MW, Jacob S, Hur K, Guter SJ, Sweeney JA, Gibbons RD, Cook EH, Bishop JR.

J Child Adolesc Psychopharmacol. 2015 Aug;25(6):467-74. doi: 10.1089/cap.2014.0158.

17.

Variation in the catechol-O-methyltransferase (COMT) gene and treatment response to venlafaxine XR in generalized anxiety disorder.

Narasimhan S, Aquino TD, Multani PK, Rickels K, Lohoff FW.

Psychiatry Res. 2012 Jun 30;198(1):112-5. doi: 10.1016/j.psychres.2011.12.034. Epub 2012 Mar 13.

PMID:
22417933
18.

Serotonin transporter gene (SLC6A4) polymorphisms are associated with response to fluoxetine in south Indian major depressive disorder patients.

Manoharan A, Shewade DG, Rajkumar RP, Adithan S.

Eur J Clin Pharmacol. 2016 Oct;72(10):1215-1220. doi: 10.1007/s00228-016-2099-9. Epub 2016 Jul 20.

PMID:
27439447
19.

Does early improvement predict endpoint response in patients with generalized anxiety disorder (GAD) treated with pregabalin or venlafaxine XR?

Baldwin DS, Schweizer E, Xu Y, Lyndon G.

Eur Neuropsychopharmacol. 2012 Feb;22(2):137-42. doi: 10.1016/j.euroneuro.2011.07.005. Epub 2011 Aug 11.

PMID:
21839620
20.

Remission rates with venlafaxine extended release in Greek outpatients with generalized anxiety disorder. A double-blind, randomized, placebo controlled study.

Nimatoudis I, Zissis NP, Kogeorgos J, Theodoropoulou S, Vidalis A, Kaprinis G.

Int Clin Psychopharmacol. 2004 Nov;19(6):331-6.

PMID:
15486518

Supplemental Content

Support Center